(RS)-(4,4-difluoro-3-(quinolin-2-yloxy)piperidin-1-yl)(4-fluorophenyl)methanone

ID: ALA3979157

PubChem CID: 134151826

Max Phase: Preclinical

Molecular Formula: C21H17F3N2O2

Molecular Weight: 386.37

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1ccc(F)cc1)N1CCC(F)(F)C(Oc2ccc3ccccc3n2)C1

Standard InChI:  InChI=1S/C21H17F3N2O2/c22-16-8-5-15(6-9-16)20(27)26-12-11-21(23,24)18(13-26)28-19-10-7-14-3-1-2-4-17(14)25-19/h1-10,18H,11-13H2

Standard InChI Key:  VKQHUBNARZWDMS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   17.1940   -0.7058    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.6068   -1.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0152   -0.7033    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.5046   -4.2923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5034   -5.1118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2115   -5.5208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2097   -3.8834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9183   -4.2887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9217   -5.1139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6273   -3.8709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3386   -4.2732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6200   -3.0537    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3245   -2.6368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3192   -1.8232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9038   -1.8307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9075   -2.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0247   -1.4108    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7346   -1.8157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7338   -2.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4428   -3.0349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4328   -1.4001    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.1424   -1.8012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1453   -2.6190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8540   -3.0236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5601   -2.6115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5532   -1.7905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8440   -1.3896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7954   -5.5199    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 16  1  0
 13 14  1  0
 14  2  1  0
  2 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 23  2  0
 22 21  2  0
 21 18  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  5 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3979157

    ---

Associated Targets(Human)

CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.37Molecular Weight (Monoisotopic): 386.1242AlogP: 4.30#Rotatable Bonds: 3
Polar Surface Area: 42.43Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.22CX LogP: 4.67CX LogD: 4.67
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.67Np Likeness Score: -1.14

References

1. Stump CA, Cooke AJ, Bruno J, Cabalu TD, Gotter AL, Harell CM, Kuduk SD, McDonald TP, O'Brien J, Renger JJ, Williams PD, Winrow CJ, Coleman PJ..  (2016)  Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacology.,  26  (23): [PMID:27818110] [10.1016/j.bmcl.2016.10.019]

Source